T-Cell Immunity to Influenza in Older Adults: A Pathophysiological Framework for Development of More Effective Vaccines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

T-Cell Immunity to Influenza in Older Adults: A Pathophysiological Framework for Development of More Effective Vaccines

Published:2016-02-25 Issue: Volume:7 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

McElhaney Janet E.,Kuchel George A.,Zhou Xin,Swain Susan L.,Haynes Laura

Funder

National Institute of Allergy and Infectious Diseases

National Institute on Aging

Canadian Institutes of Health Research

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference106 articles.

1. Viral pneumonia;Ruuskanen;Lancet,2011

2. Influenza and the winter increase in mortality in the United States, 1959-1999;Reichert;Am J Epidemiol,2004

3. Impact of respiratory virus infections on persons with chronic underlying conditions;Glezen;JAMA,2000

4. Influenza-associated hospitalizations in the United States;Thompson;JAMA,2004

5. Mortality associated with influenza and respiratory syncytial virus in the United States;Thompson;JAMA,2003

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ascorbic Acid and α-Tocopherol in the Inactivated SARS-CoV-2 Vaccine Formulation: Induction of the Th1 Pattern in Aged Mice;Viral Immunology;2024-08-30

2. The Memory-CD8+-T-Cell Response to Conserved Influenza Virus Epitopes in Mice Is Not Influenced by Time Since Previous Infection;Vaccines;2024-04-15

3. Immunogenicity, Safety, and Efficacy of Influenza Vaccine in T2DM and T2DM with Chronic Kidney Disease;Vaccines;2024-02-23

4. Time lapses between distribution of influenza vaccines to health authorities and their administration by General Practitioners (GPs) to older adults: a retrospective study over five influenza seasons in Italy;Expert Review of Vaccines;2023-12-11

5. Immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate: a randomised, double-blind, placebo-controlled, phase 2a trial;The Lancet Infectious Diseases;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3